<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39411033</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>18</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">1302-7123</ISSN><JournalIssue CitedMedium="Print"><Volume>58</Volume><Issue>3</Issue><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>Sisli Etfal Hastanesi tip bulteni</Title><ISOAbbreviation>Sisli Etfal Hastan Tip Bul</ISOAbbreviation></Journal><ArticleTitle>The Role of Dynamic Changes in Hematologic and Biochemical Parameters in Predicting Mortality in Covid-19 Patients.</ArticleTitle><Pagination><StartPage>371</StartPage><EndPage>380</EndPage><MedlinePgn>371-380</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.14744/SEMB.2024.26096</ELocationID><Abstract><AbstractText Label="OBJECTIVES" NlmCategory="UNASSIGNED">The role of hematologic, inflammatory and biochemical parameters as biomarkers, their role in identifying risky patients in the early stage and their role in prognosis in COVID-19 Coronavirus disease 2019 (COVID-19) were investigated.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">The study included patients who were hospitalized and followed up with a prediagnosis of COVID-19 in the first wave in our country at the University of Health Sciences, Sisli Hamidiye Etfal Training and Research Hospital Demographic and clinical characteristics as well as complete blood count, C reactive protein (CRP), procalcitonin (PCT), fibrinogen (FIB), ferritin, albumin (ALB), lactate dehydrogenase (LDH) levels on admission, third, seventh and 14th days were analyzed. Patients were grouped and compared according to the occurrence of death during hospital follow-up. Variables considered significant on mortality were analyzed with univariate and multivariate logistic regression models.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">The study was conducted with 485 patients, 273 (56.3%) males and 212 (43.72%) females. The mean age of the patients was 58±16.2 years, and 71% were in the mild-moderate and 29% in the severe-critical disease group. Disease severity, the need for intensive care unit (ICU) follow-up, and the development of death were positively correlated with age, comorbidity, neutrophil (NE), leukocyte, neutrophil-lymphocyte ratio (NLR), PCT, CRP, ferritin, LDH values, and negatively correlated with lymphocyte (LE), ALB and hemoglobin (HGB) values. In multivariate analysis, elevated PCT at hospital admission (OR: 6.96 [1.63;39.65]), LDH ≥ 352U/L (OR: 4.35 [1.23;16.61]), LE&lt;0.810 × 109/L (OR: 3.0 [1.16;7.85]) and advanced age (OR: 1.08 [1.03;1.14]) were independently associated with in-hospital death. In hemogram and acute phase reactant monitoring, PCT, CRP and LDH were the most valuable markers for predicting death, respectively (third-day AUC: 0.90;0.83;0.83 and seventh-day AUC: 0.95;0.90;0.89, respectively).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">In our study, leukocytes, lymphocytes, NLR, CRP, PCT, ferritin, albumin and LDH at admission were valuable in predicting poor prognosis. In addition, it was determined that increases in PCT, LDH and CRP during follow-up could be used to predict in-hospital death and to identify patients requiring close follow-up.</AbstractText><CopyrightInformation>© Copyright 2024 by The Medical Bulletin of Sisli Etfal Hospital.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Celik Tellioglu</LastName><ForeName>Emine</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases, University of Health Sciences Türkiye, Gaziosmanpasa Training and Research Hospital, Istanbul, Türkiye.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oncul</LastName><ForeName>Ahsen</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases, University of Health Sciences Türkiye, Sisli Hamidiye Etfal Training and Research Hospital, Istanbul, Türkiye.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Diktas</LastName><ForeName>Husrev</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases, University of Health Sciences Türkiye, Sisli Hamidiye Etfal Training and Research Hospital, Istanbul, Türkiye.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Atasoy Tahtasakal</LastName><ForeName>Ceren</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases, University of Health Sciences Türkiye, Sisli Hamidiye Etfal Training and Research Hospital, Istanbul, Türkiye.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aktas</LastName><ForeName>Elif</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Microbiology, University of Health Sciences Türkiye, Sisli Hamidiye Etfal Training and Research Hospital, Istanbul, Türkiye.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Genc Yaman</LastName><ForeName>Irem</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases, University of Health Sciences Türkiye, Sisli Hamidiye Etfal Training and Research Hospital, Istanbul, Türkiye.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yildiz Sevgi</LastName><ForeName>Dilek</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases, University of Health Sciences Türkiye, Sisli Hamidiye Etfal Training and Research Hospital, Istanbul, Türkiye.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dokmetas</LastName><ForeName>Ilyas</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases, University of Health Sciences Türkiye, Sisli Hamidiye Etfal Training and Research Hospital, Istanbul, Türkiye.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>Turkey</Country><MedlineTA>Sisli Etfal Hastan Tip Bul</MedlineTA><NlmUniqueID>9424130</NlmUniqueID><ISSNLinking>1302-7123</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">lymphopenia</Keyword><Keyword MajorTopicYN="N">mortality</Keyword><Keyword MajorTopicYN="N">neutrophil-lymphocyte ratio</Keyword><Keyword MajorTopicYN="N">procalcitonin</Keyword><Keyword MajorTopicYN="N">prognosis</Keyword></KeywordList><CoiStatement>None declared.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>1</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>3</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>4</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>16</Day><Hour>10</Hour><Minute>20</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>16</Day><Hour>10</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>16</Day><Hour>4</Hour><Minute>16</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>30</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39411033</ArticleId><ArticleId IdType="pmc">PMC11472194</ArticleId><ArticleId IdType="doi">10.14744/SEMB.2024.26096</ArticleId><ArticleId IdType="pii">SEMB-58-371</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Wang W, Xu Y, Gao R, Lu R, Han K, Wu G, et al. Detection of SARS-CoV-2 in different types of clinical specimens. JAMA. 2020;323:1843–4. doi: 10.1001/jama.2020.3786.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.3786</ArticleId><ArticleId IdType="pmc">PMC7066521</ArticleId><ArticleId IdType="pubmed">32159775</ArticleId></ArticleIdList></Reference><Reference><Citation>Looi MK. Covid-19: WHO adds JN.1 as new variant of interest. BMJ. 2023;383:2975. doi: 10.1136/bmj.p2975.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.p2975</ArticleId><ArticleId IdType="pubmed">38128957</ArticleId></ArticleIdList></Reference><Reference><Citation>Esper FP, Adhikari TM, Tu ZJ, Cheng YW, El-Haddad K, Farkas DH, et al. Alpha to omicron: disease severity and clinical outcomes of major SARS-CoV-2 variants. J Infect Dis. 2023;227:344–52. doi: 10.1093/infdis/jiac411.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiac411</ArticleId><ArticleId IdType="pmc">PMC9619650</ArticleId><ArticleId IdType="pubmed">36214810</ArticleId></ArticleIdList></Reference><Reference><Citation>Siavoshi F, Safavi-Naini SAA, Shirzadeh Barough S, Azizmohammad Looha M, Hatamabadi H, Ommi D, et al. On-admission and dynamic trend of laboratory profiles as prognostic biomarkers in COVID-19 inpatients. Sci Rep. 2023;13:6993. doi: 10.1038/s41598-023-34166-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-023-34166-z</ArticleId><ArticleId IdType="pmc">PMC10144885</ArticleId><ArticleId IdType="pubmed">37117397</ArticleId></ArticleIdList></Reference><Reference><Citation>Trofin F, Nastase EV, Vâță A, Iancu LS, Luncă C, Buzilă ER, et al. The immune, inflammatory and hematological response in COVID-19 patients, according to the severity of the disease. Microorganisms. 2023;11:319. doi: 10.3390/microorganisms11020319.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/microorganisms11020319</ArticleId><ArticleId IdType="pmc">PMC9967162</ArticleId><ArticleId IdType="pubmed">36838284</ArticleId></ArticleIdList></Reference><Reference><Citation>Malik P, Patel U, Mehta D, Patel N, Kelkar R, Akrmah M, et al. Biomarkers and outcomes of COVID-19 hospitalisations: systematic review and meta-analysis. BMJ Evid Based Med. 2021;26:107–8. doi: 10.1136/bmjebm-2020-111536.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjebm-2020-111536</ArticleId><ArticleId IdType="pmc">PMC7493072</ArticleId><ArticleId IdType="pubmed">32934000</ArticleId></ArticleIdList></Reference><Reference><Citation>Calim A, Yanic U, Halefoglu AM, Damar A, Ersoy C, Topcu H, et al. Is there a relationship between epicardial adipose tissue, inflammatory markers, and the severity of COVID-19 pneumonia? Sisli Etfal Hastan Tip Bul. 2023;57:387–96. doi: 10.14744/SEMB.2023.99582.</Citation><ArticleIdList><ArticleId IdType="doi">10.14744/SEMB.2023.99582</ArticleId><ArticleId IdType="pmc">PMC10600611</ArticleId><ArticleId IdType="pubmed">37900326</ArticleId></ArticleIdList></Reference><Reference><Citation>Halpin SJ, McIvor C, Whyatt G, Adams A, Harvey O, McLean L, et al. Postdischarge symptoms and rehabilitation needs in survivors of COVID-19 infection: a cross-sectional evaluation. J Med Virol. 2021;93:1013–22. doi: 10.1002/jmv.26368.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.26368</ArticleId><ArticleId IdType="pubmed">32729939</ArticleId></ArticleIdList></Reference><Reference><Citation>Ponti G, Maccaferri M, Ruini C, Tomasi A, Ozben T. Biomarkers associated with COVID-19 disease progression. Crit Rev Clin Lab Sci. 2020;57:389–99. doi: 10.1080/10408363.2020.1770685.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/10408363.2020.1770685</ArticleId><ArticleId IdType="pmc">PMC7284147</ArticleId><ArticleId IdType="pubmed">32503382</ArticleId></ArticleIdList></Reference><Reference><Citation>Thompson S, Bohn MK, Mancini N, Loh TP, Wang CB, Grimmler M, et al. IFCC Taskforce on COVID-19. IFCC Interim Guidelines on biochemical/hematological monitoring of COVID-19 patients. Clin Chem Lab Med. 2020;58:2009–16.</Citation><ArticleIdList><ArticleId IdType="pubmed">33027044</ArticleId></ArticleIdList></Reference><Reference><Citation>Frater JL, Zini G, d'Onofrio G, Rogers HJ. COVID-19 and the clinical hematology laboratory. Int J Lab Hematol. 2020;42:11–8. doi: 10.1111/ijlh.13229.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ijlh.13229</ArticleId><ArticleId IdType="pmc">PMC7264622</ArticleId><ArticleId IdType="pubmed">32311826</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen R, Sang L, Jiang M, Yang Z, Jia N, Fu W, et al. Medical Treatment Expert Group for COVID-19. Longitudinal hematologic and immunologic variations associated with the progression of COVID-19 patients in China. J Allergy Clin Immunol. 2020;146:89–100. doi: 10.1016/j.jaci.2020.05.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2020.05.003</ArticleId><ArticleId IdType="pmc">PMC7212968</ArticleId><ArticleId IdType="pubmed">32407836</ArticleId></ArticleIdList></Reference><Reference><Citation>Słomka A, Kowalewski M, Żekanowska E. Coronavirus Disease 2019 (COVID-19): a short review on hematological manifestations. Pathogens. 2020;9:493. doi: 10.3390/pathogens9060493.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/pathogens9060493</ArticleId><ArticleId IdType="pmc">PMC7350358</ArticleId><ArticleId IdType="pubmed">32575786</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoo EH, Chang SH, Song DY, Lee CH, Cheong GY, Park S, et al. Comprehensive laboratory data analysis to predict the clinical severity of Coronavirus Disease 2019 in 1,952 patients in Daegu, Korea. Ann Lab Med. 2022;42:24–35. doi: 10.3343/alm.2022.42.1.24.</Citation><ArticleIdList><ArticleId IdType="doi">10.3343/alm.2022.42.1.24</ArticleId><ArticleId IdType="pmc">PMC8368228</ArticleId><ArticleId IdType="pubmed">34374346</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan X, Li F, Wang X, Yan J, Zhu F, Tang S, et al. Neutrophil to lymphocyte ratio as prognostic and predictive factor in patients with coronavirus disease 2019: a retrospective cross-sectional study. J Med Virol. 2020;92:2573–81. doi: 10.1002/jmv.26061.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.26061</ArticleId><ArticleId IdType="pmc">PMC7283791</ArticleId><ArticleId IdType="pubmed">32458459</ArticleId></ArticleIdList></Reference><Reference><Citation>Zayed NE, Abbas A, Lutfy SM. Criteria and potential predictors of severity in patients with COVID-19. Egypt J Bronchol. 2022;16:11. doi: 10.1186/s43168-022-00116-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s43168-022-00116-y</ArticleId></ArticleIdList></Reference><Reference><Citation>Hulkoti VS, Acharya S, Kumar S, Talwar D, Khanna S, Annadatha A, et al. Association of serum ferritin with COVID-19 in a cross-sectional study of 200 intensive care unit patients in a rural hospital: is ferritin the forgotten biomarker of mortality in severe COVID-19? J Family Med Prim Care. 2022;11:2045–50. doi: 10.4103/jfmpc.jfmpc_1921_21.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/jfmpc.jfmpc_1921_21</ArticleId><ArticleId IdType="pmc">PMC9254844</ArticleId><ArticleId IdType="pubmed">35800544</ArticleId></ArticleIdList></Reference><Reference><Citation>Taneri PE, Gómez-Ochoa SA, Llanaj E, Raguindin PF, Rojas LZ, Roa-Díaz ZM, et al. Anemia and iron metabolism in COVID-19: a systematic review and meta-analysis. Eur J Epidemiol. 2020;35:763–73. doi: 10.1007/s10654-020-00678-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10654-020-00678-5</ArticleId><ArticleId IdType="pmc">PMC7438401</ArticleId><ArticleId IdType="pubmed">32816244</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhimraj A, Morgan RL, Shumaker AH, Lavergne V, Baden L, Cheng VC, et al. Infectious Diseases Society of America Guidelines on the treatment and management of patients with COVID-19. Clin Infect Dis. 2020:ciaa478. doi: 10.1093/cid/ciaa478.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa478</ArticleId><ArticleId IdType="pmc">PMC7197612</ArticleId><ArticleId IdType="pubmed">32338708</ArticleId></ArticleIdList></Reference><Reference><Citation>Sağlık Bakanlığı T. C. Erişkin hasta tedavisi.  Available at:  https://covid19.saglik.gov.tr/TR-66926/eriskin-hasta-tedavisi.html. Accessed Jul 17, 2024.</Citation></Reference><Reference><Citation>Huang I, Pranata R, Lim MA, Oehadian A, Alisjahbana B. C-reactive protein, procalcitonin, D-dimer, and ferritin in severe coronavirus disease-2019: a meta-analysis. Ther Adv Respir Dis. 2020;14:1753466620937175. doi: 10.1177/1753466620937175.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1753466620937175</ArticleId><ArticleId IdType="pmc">PMC7336828</ArticleId><ArticleId IdType="pubmed">32615866</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar A, Karn E, Trivedi K, Kumar P, Chauhan G, Kumari A, et al. Procalcitonin as a predictive marker in COVID-19: a systematic review and meta-analysis. PLoS One. 2022;17:e0272840. doi: 10.1371/journal.pone.0272840.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0272840</ArticleId><ArticleId IdType="pmc">PMC9462680</ArticleId><ArticleId IdType="pubmed">36084093</ArticleId></ArticleIdList></Reference><Reference><Citation>Euden J, Pallmann P, Grozeva D, Albur M, Bond SE, Brookes-Howell L, et al. PEACH Study Group. Procalcitonin evaluation of antibiotic use in COVID-19 hospitalised patients (PEACH): protocol for a retrospective observational study. Methods Protoc. 2022;5:95. doi: 10.3390/mps5060095.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/mps5060095</ArticleId><ArticleId IdType="pmc">PMC9786133</ArticleId><ArticleId IdType="pubmed">36548137</ArticleId></ArticleIdList></Reference><Reference><Citation>Mikami T, Miyashita H, Yamada T, Harrington M, Steinberg D, Dunn A, et al. Risk factors for mortality in patients with COVID-19 in New York City. J Gen Intern Med. 2021;36:17–26. doi: 10.1007/s11606-020-05983-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11606-020-05983-z</ArticleId><ArticleId IdType="pmc">PMC7325642</ArticleId><ArticleId IdType="pubmed">32607928</ArticleId></ArticleIdList></Reference><Reference><Citation>Castro-Castro MJ, García-Tejada L, Arbiol-Roca A, Sánchez-Navarro L, Rapún-Mas L, Cachon-Suárez I, et al. Dynamic profiles and predictive values of some biochemical and haematological quantities in COVID-19 inpatients. Biochem Med (Zagreb) 2022;32:10706. doi: 10.11613/BM.2022.010706.</Citation><ArticleIdList><ArticleId IdType="doi">10.11613/BM.2022.010706</ArticleId><ArticleId IdType="pmc">PMC8833247</ArticleId><ArticleId IdType="pubmed">35210926</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>